Trending Market News

Moderna announced on April 21 that the European Commission has approved its combination vaccine targeting both influenza and COVID-19 for adults aged 50 and older. This marks the first regulatory approval for Moderna's combo shot in the European market, offering a streamlined vaccination option for senior populations.

• The marketing authorization applies specifically to adults 50 years of age and older in European Union member states
• The combination vaccine allows simultaneous protection against both flu and COVID-19 in a single shot, potentially improving vaccination compliance among seniors
• This approval expands Moderna's mRNA vaccine portfolio beyond standalone COVID-19 products in the EU market

UPS and FedEx have begun filing for tariff refunds through a new government portal after the Supreme Court ruled in February that tariffs collected under the International Emergency Economic Powers Act were unconstitutional. The refund process could take up to three months, with both shipping companies committing to pass refunds through to customers who initially bore the charges.

• The refund portal only covers tariffs collected under IEEPA that were ruled unconstitutional; other tariffs under Section 232 and Section 301 remain in place
• U.S. Customs and Border Protection will process refund requests in phases, with the first phase covering only entries finalized within the last 80 days
• UPS estimates it could take up to three months to receive refunds from CBP before issuing them to customers, who do not need to contact the company directly

President Trump indicated on Tuesday that the federal government might provide assistance to Spirit Airlines, which is facing potential liquidation. Speaking on CNBC's 'Squawk on the Street,' Trump expressed support for either a merger or direct government aid for the struggling discount carrier.

• Trump stated he would support a merger, saying 'I'd love somebody to buy Spirit' and acknowledged the airline is 'in trouble'
• The President suggested possible federal government intervention to help Spirit Airlines avoid liquidation
• This marks a potential shift in administration policy toward assisting a struggling budget airline amid financial distress

AstraZeneca CEO warned that Germany may not receive new drug launches if the country proceeds with plans to tighten pharmaceutical spending controls. Germany's coalition government announced proposals to reduce a 20 billion euro health insurance funding gap by imposing steeper mandatory discounts on patented drugs. The drugmaker cited pressure from U.S. pricing policies as a key factor forcing difficult decisions about market access.

• Germany plans to implement variable discounts on patented drugs tied to overall expenditures and contributions, which AstraZeneca's CEO called 'a dangerous backward step'
• The threat reflects broader industry pushback against U.S. most-favored-nation pricing efforts that would tie American drug prices to lower European levels
• AstraZeneca's CEO warned Europe risks becoming merely a sales region rather than a hub for research, development, and manufacturing if pricing pressures continue

U.S. retail sales rose 1.7% in March, exceeding the 1.4% forecast, primarily driven by a 24.1% surge in gasoline prices resulting from the U.S.-Israeli conflict with Iran. The increase was also supported by higher auto sales and tax refunds, though core retail sales excluding volatile categories grew a more modest 0.7%.

• Global oil prices jumped over 30% due to the Iran conflict, adding an estimated $857 to Americans' average annual gasoline costs for the year
• Core retail sales (excluding autos, gas, building materials, and food services) rose 0.7%, suggesting consumer spending growth slowed from Q4's 1.9% annualized rate
• Consumer sentiment fell to a record low in April amid concerns that high gas prices could divert spending from other sectors and erode tax refunds

Swedish trucking company Einride has partnered with Amazon to deploy 75 electric heavy-duty trucks and charging infrastructure across five U.S. locations for Amazon's freight network. The partnership leverages Einride's Saga AI software for fleet management and represents Amazon's strategy of working with third-party operators to advance electrification without directly owning all assets. This comes as the U.S. electric trucking market faces challenges and slower-than-expected adoption.

• Einride's proprietary Saga AI optimization software will manage electric vehicle execution for select Amazon loads, including charging planning
• Amazon is increasingly relying on operators like Einride that provide vehicles, charging infrastructure, and fleet-management software rather than owning and operating all electrification assets directly
• The U.S. electric trucking market has struggled to meet early expectations, with setbacks at companies like Nikola and slower rollouts of Amazon's electric delivery vans developed with Rivian

Quest Diagnostics raised its 2026 profit and revenue outlook after first-quarter results exceeded Wall Street expectations, driven by strong demand for routine diagnostic testing. The company now expects full-year revenue between $11.78 billion and $11.90 billion, up from its previous forecast, as it navigates post-pandemic normalization with hospital laboratory management deals and routine testing volumes.

• Quest's Diagnostic Information Services revenue rose 9.4% year-over-year to $2.83 billion, with organic requisition volumes up 10.8%, though revenue per test fell 1.3%
• First-quarter revenue reached $2.90 billion versus analyst estimates of $2.83 billion, with adjusted profit of $2.50 per share beating expectations
• The company reported double-digit revenue growth in advanced diagnostics including Alzheimer's blood tests and cardiometabolic testing, though analysts caution new hospital contracts may pressure margins initially

Danaher exceeded first-quarter profit expectations on April 21, reporting adjusted earnings of $2.06 per share, driven by strong demand for bioprocessing tools used in drug manufacturing. The results indicate improving market conditions for life sciences companies as pharmaceutical firms increase spending on drug discovery and development.

• The bioprocessing unit was the standout performer with core sales up 7% for the quarter, while total quarterly revenue of $5.95 billion slightly missed Wall Street estimates of $6 billion
• Life sciences segment core sales rose 0.5%, but the diagnostics unit (including COVID-19 testing kits) saw sales decline 4% amid weaker seasonal demand for respiratory tests
• Danaher raised its full-year adjusted earnings forecast to $8.35-$8.55 per share and expressed optimism about its acquisition of Masimo Corporation announced in February

Defense contractor RTX raised its 2026 profit and revenue forecasts on Tuesday, driven by strong demand for missile systems and weapons amid heightened geopolitical tensions. The company benefits from Pentagon efforts to replenish stockpiles depleted by conflicts in Ukraine and Gaza, as well as robust aircraft maintenance demand due to airline supply chain disruptions.

• RTX secured a $3.7 billion contract in April to supply Patriot GEM-T interceptor missiles to Ukraine, while its Raytheon unit saw first-quarter sales jump 10% to $6.95 billion
• First-quarter revenue rose 9% year-over-year to $22.08 billion, with commercial aftermarket sales up 19% in the Pratt and Whitney segment as airlines maintain aging fleets
• The company lifted its 2026 revenue forecast to $92.5-$93.5 billion from $92-$93 billion previously, citing sustained aftermarket sales and growing weapons demand

Merck and Eisai announced that their experimental combination treatments for a type of kidney cancer failed to meet the primary endpoints in a late-stage clinical trial. The setback affects the companies' joint development efforts in oncology. This news represents a significant clinical disappointment for the pharmaceutical partners' cancer drug pipeline.

• The experimental combination therapy was being tested for a specific type of kidney cancer in a late-stage study
• The treatment failed to achieve its main goals, indicating the drug combination did not demonstrate sufficient efficacy in the trial
• This failure impacts Merck and Eisai's collaborative oncology development program and may affect their strategic plans in kidney cancer treatment

Halliburton reported increased first-quarter profit on Tuesday, with net income reaching $461 million, or 55 cents per share. The oilfield services provider benefited from steady demand in Latin America and European markets, which offset a slowdown in Middle East activity due to the Iran war.

• Net income attributable to the company was $461 million, or 55 cents per share
• Strong performance in Latin America and European markets compensated for reduced activity levels
• Middle East operations experienced a slowdown due to the Iran war

Northrop Grumman reported a 4.4% increase in first-quarter revenue to $9.88 billion, driven by strong demand for aeronautics systems including the B-21 Raider aircraft and nuclear missile programs. The growth reflects increased Pentagon procurement amid global conflicts straining weapons stockpiles, with the company maintaining its 2026 sales forecast of $43.5 to $44 billion.

• Aeronautics segment sales rose 17% to $3.28 billion, boosted by a February agreement to expand B-21 Raider production by 25% with first deliveries scheduled for 2027 at $692 million per aircraft
• Defense systems segment saw 10% organic sales growth to $1.9 billion, driven by the Sentinel nuclear missile program (replacing Minuteman III) with first flight expected in 2027
• Pentagon efforts to rebuild weapons stockpiles depleted by Iran-linked operations and other conflicts are fueling sustained demand for defense contractors

India's Competition Commission (CCI) has changed AB InBev's status from witness to 'party under investigation' in a cartel probe involving 42 alcohol retailers in Telangana state, allegedly excluding AB InBev's rivals. The world's largest brewer secured a temporary court injunction in April 2025, arguing the status change was illegal without prior notice. If the investigation proceeds, AB InBev could face penalties up to three times its profit or 10% of annual turnover.

• AB InBev cooperated as a witness for four years (2022-2025) and shared sensitive business information before being reclassified as an accused party in November 2025 without prior notice or hearing
• The CCI alleges retailers formed a cartel to exclusively stock AB InBev products and receive special incentives, excluding rivals Heineken (50% market share), Carlsberg (19%), and United Breweries from India's $10 billion beer market
• This is India's toughest beer sector enforcement since 2021 when Heineken and Carlsberg were collectively fined over $100 million for price collusion, a case where AB InBev was a witness

Russia will halt Kazakhstan's oil shipments to Germany through the Druzhba pipeline starting May 1, according to industry sources who confirmed updated export schedules have been sent to both countries. The move comes amid deteriorating Russia-Germany relations over the Ukraine conflict and affects a key supply route for Germany's PCK refinery in Schwedt.

• Kazakhstan exported 2.146 million metric tons (approximately 43,000 barrels per day) of oil to Germany via Druzhba in 2025, a 44% increase from 2024
• Germany's PCK refinery in Schwedt has relied on Kazakh crude via this pipeline since Russian oil deliveries stopped in 2022 following Moscow's invasion of Ukraine
• The pipeline route through Russia and Poland has faced repeated interruptions from Ukrainian drone attacks on Russian territory

U.S. Trade Representative Jamieson Greer informed Mexican auto and steel industries that Trump's tariffs will remain in place even after USMCA renegotiation, marking the first time the administration has explicitly stated tariffs won't return to zero. Mexico faces 25% tariffs on automotive imports and steel products, putting it at a disadvantage compared to countries like Japan and the EU that secured lower rates. Formal bilateral talks are set to begin the week of May 25 ahead of a July 1 USMCA review deadline.

• Mexico's auto exports to the U.S. fell nearly 3% in 2025 after Trump imposed 25% tariffs in March 2025, with the sector losing about 60,000 jobs and facing deeper declines if tariffs persist
• U.S. negotiators proposed requiring 100% of key auto components (engines, major electronics, software) be sourced from North America, up from the current 75% regional value content requirement under USMCA
• Mexico now faces higher effective tariffs than competitors, as Trump granted lower rates to Japan, the EU, and South Korea (15%) and Britain (10%) on automotive imports

JPMorgan Chase is expanding its $1.5 trillion Security and Resiliency Initiative (SRI) to continental Europe after launching it in the U.S. and U.K. last year. The 10-year program aims to finance and invest in industries critical to economic security, including defense, energy, healthcare, and strategic technologies. CEO Jamie Dimon emphasized reducing reliance on unpredictable sources for critical materials essential to collective security and prosperity.

• The initiative focuses on five key European countries - U.K., France, Germany, Poland, and Italy - while including all EU and NATO member states in the strategy.
• Investment targets include around 30 subsectors spanning shipbuilding, spacecraft, nuclear energy, cybersecurity, semiconductors, and critical minerals supply chains.
• JPMorgan will provide preferential credit terms for SRI-aligned companies, including smaller size deals than typically expected, to scale up Western capabilities in strategic sectors.

SpaceX plans to maintain founder Elon Musk's control through a dual-class voting structure in its upcoming IPO, which targets a $1.75 trillion valuation with a $75 billion raise, making it the largest IPO in history. The company's confidentially filed prospectus reveals it ended 2025 with $24.8 billion cash but swung to a $4.94 billion loss due to heavy AI infrastructure investments following its acquisition of xAI.

• SpaceX will use dual-class shares giving Musk and insiders super-voting rights, with Musk continuing as CEO, CTO, and board chairman despite earning only $54,080 in salary last year
• The combined company reported $92 billion in assets against $50.8 billion in liabilities, with Starlink generating $4.42 billion in operating profit to offset losses from xAI integration
• Capital expenditure surged to $20.74 billion in 2025 (more than double the prior year), with over half ($12.7 billion) directed toward AI spending, though still far below Meta's $72 billion AI infrastructure investment

Sweden's Supreme Court acquitted former Swedbank CEO Birgitte Bonnesen on April 21, overturning a lower court's 15-month prison sentence for gross fraud related to misleading statements about anti-money laundering measures at the bank's Estonian branch. The Supreme Court ruled that Bonnesen's 2018 statements to media were protected by freedom of speech.

• An appeals court in 2024 had found Bonnesen guilty of gross fraud for misleading statements made in October 2018 about anti-money laundering work at Swedbank's Estonian branch
• The Supreme Court determined her answers were covered by freedom of speech protections, leading to full acquittal
• Bonnesen served as Swedbank CEO from 2016 to 2019 and had consistently denied all charges against her

AstraZeneca announced that its drug Ultomiris successfully met the primary endpoint in a late-stage clinical trial for a rare kidney disease. The trial demonstrated a reduction in urinary protein levels among patients with the condition. Ultomiris is currently approved for treating rare blood disorders.

• Ultomiris achieved its main goal by reducing protein levels in urine of patients with a rare kidney disease
• The drug is currently marketed for rare blood disorders and this trial represents potential expansion into kidney disease treatment
• The successful late-stage trial results could open new market opportunities for AstraZeneca in rare disease therapeutics

U.S. cosmetics giant Estee Lauder has enlisted J.P. Morgan to arrange approximately 5 billion euros ($5.89 billion) in financing for a potential takeover of Spanish beauty company Puig, according to sources cited by Spanish newspaper Expansion. The deal would create the world's largest premium beauty player, combining major brands like Tom Ford, Carolina Herrera, Clinique, and Jean Paul Gaultier under one corporate umbrella.

• J.P. Morgan has been commissioned to structure a financing package of around 5 billion euros for the acquisition
• The combined entity would become the world's largest premium beauty player, merging portfolios that include Tom Ford, Carolina Herrera, Rabanne, Jean Paul Gaultier, and Clinique
• Estee Lauder and Puig announced last month they were exploring a potential combination deal